CXCR4 involvement in neurodegenerative diseases

International FTD-Genomics Consortium (IFGC) , Gianluigi Forloni, Diego Albani

Research output: Contribution to journalArticle

Abstract

Neurodegenerative diseases likely share common underlying pathobiology. Although prior work has identified susceptibility loci associated with various dementias, few, if any, studies have systematically evaluated shared genetic risk across several neurodegenerative diseases. Using genome-wide association data from large studies (total n = 82,337 cases and controls), we utilized a previously validated approach to identify genetic overlap and reveal common pathways between progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), Parkinson's disease (PD) and Alzheimer's disease (AD). In addition to the MAPT H1 haplotype, we identified a variant near the chemokine receptor CXCR4 that was jointly associated with increased risk for PSP and PD. Using bioinformatics tools, we found strong physical interactions between CXCR4 and four microglia related genes, namely CXCL12, TLR2, RALB, and CCR5. Evaluating gene expression from post-mortem brain tissue, we found that expression of CXCR4 and microglial genes functionally related to CXCR4 was dysregulated across a number of neurodegenerative diseases. Furthermore, in a mouse model of tauopathy, expression of CXCR4 and functionally associated genes was significantly altered in regions of the mouse brain that accumulate neurofibrillary tangles most robustly. Beyond MAPT, we show dysregulation of CXCR4 expression in PSP, PD, and FTD brains, and mouse models of tau pathology. Our multi-modal findings suggest that abnormal signaling across a 'network' of microglial genes may contribute to neurodegeneration and may have potential implications for clinical trials targeting immune dysfunction in patients with neurodegenerative diseases.

Original languageEnglish
Pages (from-to)73
JournalTranslational Psychiatry
Volume8
Issue number1
DOIs
Publication statusPublished - Apr 11 2018

Fingerprint

Progressive Supranuclear Palsy
Neurodegenerative Diseases
Parkinson Disease
Frontotemporal Dementia
Brain
Tauopathies
Genes
Neurofibrillary Tangles
Gene Regulatory Networks
Chemokine Receptors
Microglia
Computational Biology
Haplotypes
Dementia
Alzheimer Disease
Clinical Trials
Genome
Pathology
Gene Expression

Keywords

  • Animals
  • Brain/metabolism
  • Gene Expression
  • Gene Regulatory Networks
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Humans
  • Mice, Transgenic
  • Microglia/metabolism
  • Neurodegenerative Diseases/genetics
  • Polymorphism, Single Nucleotide
  • Receptors, CXCR4/genetics
  • Risk Factors

Cite this

CXCR4 involvement in neurodegenerative diseases. / International FTD-Genomics Consortium (IFGC) ; Forloni, Gianluigi; Albani, Diego.

In: Translational Psychiatry, Vol. 8, No. 1, 11.04.2018, p. 73.

Research output: Contribution to journalArticle

International FTD-Genomics Consortium (IFGC) ; Forloni, Gianluigi ; Albani, Diego. / CXCR4 involvement in neurodegenerative diseases. In: Translational Psychiatry. 2018 ; Vol. 8, No. 1. pp. 73.
@article{15af116b078145a18768a5a98febf279,
title = "CXCR4 involvement in neurodegenerative diseases",
abstract = "Neurodegenerative diseases likely share common underlying pathobiology. Although prior work has identified susceptibility loci associated with various dementias, few, if any, studies have systematically evaluated shared genetic risk across several neurodegenerative diseases. Using genome-wide association data from large studies (total n = 82,337 cases and controls), we utilized a previously validated approach to identify genetic overlap and reveal common pathways between progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), Parkinson's disease (PD) and Alzheimer's disease (AD). In addition to the MAPT H1 haplotype, we identified a variant near the chemokine receptor CXCR4 that was jointly associated with increased risk for PSP and PD. Using bioinformatics tools, we found strong physical interactions between CXCR4 and four microglia related genes, namely CXCL12, TLR2, RALB, and CCR5. Evaluating gene expression from post-mortem brain tissue, we found that expression of CXCR4 and microglial genes functionally related to CXCR4 was dysregulated across a number of neurodegenerative diseases. Furthermore, in a mouse model of tauopathy, expression of CXCR4 and functionally associated genes was significantly altered in regions of the mouse brain that accumulate neurofibrillary tangles most robustly. Beyond MAPT, we show dysregulation of CXCR4 expression in PSP, PD, and FTD brains, and mouse models of tau pathology. Our multi-modal findings suggest that abnormal signaling across a 'network' of microglial genes may contribute to neurodegeneration and may have potential implications for clinical trials targeting immune dysfunction in patients with neurodegenerative diseases.",
keywords = "Animals, Brain/metabolism, Gene Expression, Gene Regulatory Networks, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Mice, Transgenic, Microglia/metabolism, Neurodegenerative Diseases/genetics, Polymorphism, Single Nucleotide, Receptors, CXCR4/genetics, Risk Factors",
author = "{International FTD-Genomics Consortium (IFGC)} and Bonham, {Luke W} and Karch, {Celeste M} and Fan, {Chun C} and Chin Tan and Geier, {Ethan G} and Yunpeng Wang and Natalie Wen and Broce, {Iris J} and Yi Li and Barkovich, {Matthew J} and Raffaele Ferrari and John Hardy and Parastoo Momeni and G{\"u}nter H{\"o}glinger and Ulrich M{\"u}ller and Hess, {Christopher P} and Sugrue, {Leo P} and Dillon, {William P} and Schellenberg, {Gerard D} and Miller, {Bruce L} and Andreassen, {Ole A} and Dale, {Anders M} and Barkovich, {A James} and Yokoyama, {Jennifer S} and Desikan, {Rahul S} and Gianluigi Forloni and Diego Albani",
year = "2018",
month = "4",
day = "11",
doi = "10.1038/s41398-017-0049-7",
language = "English",
volume = "8",
pages = "73",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - CXCR4 involvement in neurodegenerative diseases

AU - International FTD-Genomics Consortium (IFGC)

AU - Bonham, Luke W

AU - Karch, Celeste M

AU - Fan, Chun C

AU - Tan, Chin

AU - Geier, Ethan G

AU - Wang, Yunpeng

AU - Wen, Natalie

AU - Broce, Iris J

AU - Li, Yi

AU - Barkovich, Matthew J

AU - Ferrari, Raffaele

AU - Hardy, John

AU - Momeni, Parastoo

AU - Höglinger, Günter

AU - Müller, Ulrich

AU - Hess, Christopher P

AU - Sugrue, Leo P

AU - Dillon, William P

AU - Schellenberg, Gerard D

AU - Miller, Bruce L

AU - Andreassen, Ole A

AU - Dale, Anders M

AU - Barkovich, A James

AU - Yokoyama, Jennifer S

AU - Desikan, Rahul S

AU - Forloni, Gianluigi

AU - Albani, Diego

PY - 2018/4/11

Y1 - 2018/4/11

N2 - Neurodegenerative diseases likely share common underlying pathobiology. Although prior work has identified susceptibility loci associated with various dementias, few, if any, studies have systematically evaluated shared genetic risk across several neurodegenerative diseases. Using genome-wide association data from large studies (total n = 82,337 cases and controls), we utilized a previously validated approach to identify genetic overlap and reveal common pathways between progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), Parkinson's disease (PD) and Alzheimer's disease (AD). In addition to the MAPT H1 haplotype, we identified a variant near the chemokine receptor CXCR4 that was jointly associated with increased risk for PSP and PD. Using bioinformatics tools, we found strong physical interactions between CXCR4 and four microglia related genes, namely CXCL12, TLR2, RALB, and CCR5. Evaluating gene expression from post-mortem brain tissue, we found that expression of CXCR4 and microglial genes functionally related to CXCR4 was dysregulated across a number of neurodegenerative diseases. Furthermore, in a mouse model of tauopathy, expression of CXCR4 and functionally associated genes was significantly altered in regions of the mouse brain that accumulate neurofibrillary tangles most robustly. Beyond MAPT, we show dysregulation of CXCR4 expression in PSP, PD, and FTD brains, and mouse models of tau pathology. Our multi-modal findings suggest that abnormal signaling across a 'network' of microglial genes may contribute to neurodegeneration and may have potential implications for clinical trials targeting immune dysfunction in patients with neurodegenerative diseases.

AB - Neurodegenerative diseases likely share common underlying pathobiology. Although prior work has identified susceptibility loci associated with various dementias, few, if any, studies have systematically evaluated shared genetic risk across several neurodegenerative diseases. Using genome-wide association data from large studies (total n = 82,337 cases and controls), we utilized a previously validated approach to identify genetic overlap and reveal common pathways between progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), Parkinson's disease (PD) and Alzheimer's disease (AD). In addition to the MAPT H1 haplotype, we identified a variant near the chemokine receptor CXCR4 that was jointly associated with increased risk for PSP and PD. Using bioinformatics tools, we found strong physical interactions between CXCR4 and four microglia related genes, namely CXCL12, TLR2, RALB, and CCR5. Evaluating gene expression from post-mortem brain tissue, we found that expression of CXCR4 and microglial genes functionally related to CXCR4 was dysregulated across a number of neurodegenerative diseases. Furthermore, in a mouse model of tauopathy, expression of CXCR4 and functionally associated genes was significantly altered in regions of the mouse brain that accumulate neurofibrillary tangles most robustly. Beyond MAPT, we show dysregulation of CXCR4 expression in PSP, PD, and FTD brains, and mouse models of tau pathology. Our multi-modal findings suggest that abnormal signaling across a 'network' of microglial genes may contribute to neurodegeneration and may have potential implications for clinical trials targeting immune dysfunction in patients with neurodegenerative diseases.

KW - Animals

KW - Brain/metabolism

KW - Gene Expression

KW - Gene Regulatory Networks

KW - Genetic Predisposition to Disease

KW - Genome-Wide Association Study

KW - Humans

KW - Mice, Transgenic

KW - Microglia/metabolism

KW - Neurodegenerative Diseases/genetics

KW - Polymorphism, Single Nucleotide

KW - Receptors, CXCR4/genetics

KW - Risk Factors

U2 - 10.1038/s41398-017-0049-7

DO - 10.1038/s41398-017-0049-7

M3 - Article

C2 - 29636460

VL - 8

SP - 73

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

IS - 1

ER -